Pain News and Research

Latest Pain News and Research

Stryker Orthopaedics introduces ADM X3 Mobile Bearing Acetabular System for hip replacement surgery

Stryker Orthopaedics today announced the release of the ADM X3 Mobile Bearing Acetabular System, a next-generation technology for hip replacement surgery designed to minimize the risks associated with total hip replacement surgery.

From Stryker 5 Mar 2010

Porter Adventist Hospital designated as Blue Distinction Center for spine surgery, knee and hip replacement programs

Porter Adventist Hospital is among the first in the country to receive designation as Blue Distinction Centers in two surgical services that have recently been added to the Blue Cross and Blue Shield Association's expansion of its Blue Distinction® designation.

5 Mar 2010

FDA takes steps to protect consumers from potential Salmonella infection

The U.S. Food and Drug Administration is taking steps to protect the public following the early identification of Salmonella Tennessee in one company's supply of hydrolyzed vegetable protein (HVP). This is a common ingredient used most frequently as a flavor enhancer in many processed foods, including soups, sauces, chilis, stews, hot dogs, gravies, seasoned snack foods, dips and dressings.

5 Mar 2010

Worm proteins may provide option in management of gastrointestinal inflammation in IBD patients

Patients with inflammatory bowel disease (IBD) suffer from chronic inflammation of the gut leading to gastrointestinal motility alterations with symptoms such as abdominal pain, cramps and diarrhea that profoundly affect their quality of life. The lack of exposure to worm infections, as a result of improved living standards and medical conditions, might have contributed to the increased incidence of IBD in the Western world.

5 Mar 2010

Patient enrollment in Phase II study of BioCart Autologous Cartilage System nearing halfway point

ProChon Biotech, Ltd., an innovator of tissue regenerative technologies that are being developed to relieve pain and restore the mobility and quality-of-life for sufferers of articular cartilage injuries, today announced that patient enrollment in the Company’s Phase II study of the BioCart™ Autologous Cartilage System is nearing the halfway point and is expected to be completed within the next three months.

5 Mar 2010

Researchers develop new model to guide health care financing, resource allocation decisions in the U.S.

A new model that can be used to guide health care financing and resource allocation decisions in the U.S. has been developed by an international group of researchers led by a team from the University of Illinois at Chicago.

5 Mar 2010

Chikungunya: Experimental vaccine successfully tested in monkeys

Imagine a mosquito-borne virus that has already infected millions of people in recent outbreaks in South and Southeast Asia, the islands of the Indian Ocean, Africa and northern Italy. Although seldom fatal, it causes highly painful arthritis-like symptoms that can linger for months or even years. It's capable of adapting to spread through a mosquito species common in much of North America. And no vaccine or treatment exists to protect humans from its effects.

5 Mar 2010

Heartburn drug Kapidex to be marketed under new name Dexilant

The U.S. Food and Drug Administration has approved a name change for the heartburn drug Kapidex (dexlansoprazole) to avoid confusion with two other medications – Casodex and Kadian. Effective in late April 2010, Takeda Pharmaceuticals North America Inc. will market Kapidex under the new name Dexilant.

4 Mar 2010

Washington State cracks down on prescription fraud with new paper and ink

The Seattle Post Intelligencer/Everett Herald: "Patients who get written prescriptions will see changes this summer aimed at curbing fraud. Come July 1, prescriptions will be printed on tamper-resistant paper with Mission Impossible-like ink that changes color when rubbed with a finger.

4 Mar 2010

Acupuncture may reduce joint pain and stiffness caused by routine breast cancer therapy

A new study, led by researchers at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center, demonstrates that acupuncture may be an effective therapy for joint pain and stiffness in breast cancer patients who are being treated with commonly used hormonal therapies. Results were published in the Journal of Clinical Oncology.

4 Mar 2010

Watson Pharmaceuticals to acquire U.S. rights to Columbia's bioadhesive progesterone gel products

Watson Pharmaceuticals, Inc. today announced an agreement to expand their Women's Health brand product portfolio with the acquisition of the exclusive U.S. rights to Columbia Laboratories, Inc.'s bioadhesive progesterone gel products currently marketed under the trade names CRINONE® and PROCHIEVE® for the indications of infertility and secondary amenorrhea.

4 Mar 2010

Top ten beauty treatments

RoxSpa, one of the most prestigious and luxurious medi-spas in Beverly Hills, announces their annual 'Top Ten' face and body rejuvenation treatments that are both highly-effective and provide the most satisfying results.

4 Mar 2010

Covidien enters into preferred vendor partnership with OSF Healthcare System

Covidien, a leading global provider of healthcare products and recognized innovator of mechanical ventilation and respiratory care devices, today announced it has entered into a long-term, preferred vendor partnership with the Order of Saint Francis (OSF) Healthcare System, headquartered in Peoria, Ill. After using a mix of SPO2 technologies for more than eight years, the OSF Healthcare System recently standardized to OxiMax™ technology for all its pulse oximetry needs.

4 Mar 2010

Embedded wireless sensors in senior's homes to detect onset of dementia or physical infirmities

Carnegie Mellon University researchers in the Quality of Life Technology Center (QoLTC) will embed wireless sensors in the residences of about 50 older adults who live alone to see if they can detect subtle changes in everyday activities that indicate the onset of dementia or physical infirmities.

4 Mar 2010

State Supreme Court weighs medical malpractice caps in case that would impact doctors, patients

The Kansas Health Institute has a package of stories about a malpractice case being considered by the Kansas Supreme Court in which the justices could determine if the state's caps on medical malpractice awards are constitutional. The case involves Amy Miller, who underwent surgery to have an ovary removed. But the surgeon took the wrong ovary and later she had the second one taken out.

4 Mar 2010

Study: 73% of disadvantaged kids in Los Angeles County have untreated caries

A huge percentage of underprivileged kids in Los Angeles County have infectious dental disease that's gone unchecked, according to a study led by the Herman Ostrow School of Dentistry of the University of Southern California.

4 Mar 2010

Kansas lawmakers debate legality of health insurance mandate amendment

Kansas Health Institute: "Republicans and Democrats were sharply divided Tuesday over a proposed constitutional amendment that sponsors said would let federal officials know Kansans don't want to be told by the government that they must buy health insurance. On a 12-9, party-line vote, the House Health and Human Services Committee voted to recommend House Concurrent Resolution 5032 favorable for passage.

4 Mar 2010

Allergan, Bristol-Myers Squibb sign global exclusive license agreement for EHT/AGN 0001

ExonHit Therapeutics today reported the signing by Allergan, Inc. and Bristol-Myers Squibb Company of a global exclusive license agreement for the development and commercialization of EHT/AGN 0001 (AGN-209323), ExonHit’s lead compound from the most advanced program of its collaboration with Allergan.

4 Mar 2010

Foodborne illness raises U.S healthcare costs

Acute foodborne illnesses cost the United States an estimated $152 billion per year in healthcare, workplace and other economic losses, according to a report published today by the Produce Safety Project (PSP).

4 Mar 2010

Covidien: Mallinckrodt launches Oral Transmucosal Fentanyl Citrate

Covidien, a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has launched its Oral Transmucosal Fentanyl Citrate (CII) to distributors serving retail pharmacies across the country.

3 Mar 2010

Pain News and Research

Latest Pain News and Research

Stryker Orthopaedics introduces ADM X3 Mobile Bearing Acetabular System for hip replacement surgery

Porter Adventist Hospital designated as Blue Distinction Center for spine surgery, knee and hip replacement programs

FDA takes steps to protect consumers from potential Salmonella infection

Worm proteins may provide option in management of gastrointestinal inflammation in IBD patients

Patient enrollment in Phase II study of BioCart Autologous Cartilage System nearing halfway point

Researchers develop new model to guide health care financing, resource allocation decisions in the U.S.

Chikungunya: Experimental vaccine successfully tested in monkeys

Heartburn drug Kapidex to be marketed under new name Dexilant

Washington State cracks down on prescription fraud with new paper and ink

Acupuncture may reduce joint pain and stiffness caused by routine breast cancer therapy

Watson Pharmaceuticals to acquire U.S. rights to Columbia's bioadhesive progesterone gel products

Top ten beauty treatments

Covidien enters into preferred vendor partnership with OSF Healthcare System

Embedded wireless sensors in senior's homes to detect onset of dementia or physical infirmities

State Supreme Court weighs medical malpractice caps in case that would impact doctors, patients

Study: 73% of disadvantaged kids in Los Angeles County have untreated caries

Kansas lawmakers debate legality of health insurance mandate amendment

Allergan, Bristol-Myers Squibb sign global exclusive license agreement for EHT/AGN 0001

Foodborne illness raises U.S healthcare costs

Covidien: Mallinckrodt launches Oral Transmucosal Fentanyl Citrate

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Pain News and Research

Latest Pain News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in